Global Breakthrough Therapy (BT) Designation Market Size, Status and Forecast 2025

Published On: July 2018 | Report ID: 48904 | Category: Pharmaceuticals and HealthcarePages: 103

This report studies the global Breakthrough Therapy (BT) Designation market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Breakthrough Therapy (BT) Designation market by companies, region, type and end-use industry.

In 2017, the global Breakthrough Therapy (BT) Designation market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global top players, covered

Roche

Abbvie

Novartis International AG

Janssen

BMS

Eli Lilly

Gilead

Sanofi

Regeneron

Acadia

Boehringer Ingelheim

Amgen

AstraZeneca

GlaxoSmithKline

Vertex

Alexion

Merck

Jazz Pharmaceuticals

Exelixis

Eisai

Takeda

Pfizer

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Market segment by Type, the product can be split into

Oncology

Infectious Diseases

Rare Diseases

Autoimmune Diseases

Pulmonary Diseases

Neurological Disorders

Others

Market segment by Application, split into

Hospital

Clinic

Research Institute

Laboratories

The study objectives of this report are:

To study and forecast the market size of Breakthrough Therapy (BT) Designation in global market.

To analyze the global key players, SWOT analysis, value and global market share for top players.

To define, describe and forecast the market by type, end use and region.

To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.

To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Breakthrough Therapy (BT) Designation are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Breakthrough Therapy (BT) Designation Manufacturers

Breakthrough Therapy (BT) Designation Distributors/Traders/Wholesalers

Breakthrough Therapy (BT) Designation Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Breakthrough Therapy (BT) Designation market, by end-use.

Detailed analysis and profiles of additional market players.

Table of Contents

Global Breakthrough Therapy (BT) Designation Market Size, Status and Forecast 2025

1 Industry Overview of Breakthrough Therapy (BT) Designation

1.1 Breakthrough Therapy (BT) Designation Market Overview

1.1.1 Breakthrough Therapy (BT) Designation Product Scope

1.1.2 Market Status and Outlook

1.2 Global Breakthrough Therapy (BT) Designation Market Size and Analysis by Regions (2013-2018)

1.2.1 United States

1.2.2 Europe

1.2.3 China

1.2.4 Japan

1.2.5 Southeast Asia

1.2.6 India

1.3 Breakthrough Therapy (BT) Designation Market by Type

1.3.1 Oncology

1.3.2 Infectious Diseases

1.3.3 Rare Diseases

1.3.4 Autoimmune Diseases

1.3.5 Pulmonary Diseases

1.3.6 Neurological Disorders

1.3.7 Others

1.4 Breakthrough Therapy (BT) Designation Market by End Users/Application

1.4.1 Hospital

1.4.2 Clinic

1.4.3 Research Institute

1.4.4 Laboratories

2 Global Breakthrough Therapy (BT) Designation Competition Analysis by Players

2.1 Breakthrough Therapy (BT) Designation Market Size (Value) by Players (2013-2018)

2.2 Competitive Status and Trend

2.2.1 Market Concentration Rate

2.2.2 Product/Service Differences

2.2.3 New Entrants

2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles

3.1 Roche

3.1.1 Company Profile

3.1.2 Main Business/Business Overview

3.1.3 Products, Services and Solutions

3.1.4 Breakthrough Therapy (BT) Designation Revenue (Million USD) (2013-2018)

3.2 Abbvie

3.2.1 Company Profile

3.2.2 Main Business/Business Overview

3.2.3 Products, Services and Solutions

3.2.4 Breakthrough Therapy (BT) Designation Revenue (Million USD) (2013-2018)

3.3 Novartis International AG

3.3.1 Company Profile

3.3.2 Main Business/Business Overview

3.3.3 Products, Services and Solutions

3.3.4 Breakthrough Therapy (BT) Designation Revenue (Million USD) (2013-2018)

3.4 Janssen

3.4.1 Company Profile

3.4.2 Main Business/Business Overview

3.4.3 Products, Services and Solutions

3.4.4 Breakthrough Therapy (BT) Designation Revenue (Million USD) (2013-2018)

3.5 BMS

3.5.1 Company Profile

3.5.2 Main Business/Business Overview

3.5.3 Products, Services and Solutions

3.5.4 Breakthrough Therapy (BT) Designation Revenue (Million USD) (2013-2018)

3.6 Eli Lilly

3.6.1 Company Profile

3.6.2 Main Business/Business Overview

3.6.3 Products, Services and Solutions

3.6.4 Breakthrough Therapy (BT) Designation Revenue (Million USD) (2013-2018)

3.7 Gilead

3.7.1 Company Profile

3.7.2 Main Business/Business Overview

3.7.3 Products, Services and Solutions

3.7.4 Breakthrough Therapy (BT) Designation Revenue (Million USD) (2013-2018)

3.8 Sanofi

3.8.1 Company Profile

3.8.2 Main Business/Business Overview

3.8.3 Products, Services and Solutions

3.8.4 Breakthrough Therapy (BT) Designation Revenue (Million USD) (2013-2018)

3.9 Regeneron

3.9.1 Company Profile

3.9.2 Main Business/Business Overview

3.9.3 Products, Services and Solutions

3.9.4 Breakthrough Therapy (BT) Designation Revenue (Million USD) (2013-2018)

3.10 Acadia

3.10.1 Company Profile

3.10.2 Main Business/Business Overview

3.10.3 Products, Services and Solutions

3.10.4 Breakthrough Therapy (BT) Designation Revenue (Million USD) (2013-2018)

3.11 Boehringer Ingelheim

3.12 Amgen

3.13 AstraZeneca

3.14 GlaxoSmithKline

3.15 Vertex

3.16 Alexion

3.17 Merck

3.18 Jazz Pharmaceuticals

3.19 Exelixis

3.20 Eisai

3.21 Takeda

3.22 Pfizer

4 Global Breakthrough Therapy (BT) Designation Market Size by Type and Application (2013-2018)

4.1 Global Breakthrough Therapy (BT) Designation Market Size by Type (2013-2018)

4.2 Global Breakthrough Therapy (BT) Designation Market Size by Application (2013-2018)

4.3 Potential Application of Breakthrough Therapy (BT) Designation in Future

4.4 Top Consumer/End Users of Breakthrough Therapy (BT) Designation

5 United States Breakthrough Therapy (BT) Designation Development Status and Outlook

5.1 United States Breakthrough Therapy (BT) Designation Market Size (2013-2018)

5.2 United States Breakthrough Therapy (BT) Designation Market Size and Market Share by Players (2013-2018)

5.3 United States Breakthrough Therapy (BT) Designation Market Size by Application (2013-2018)

6 Europe Breakthrough Therapy (BT) Designation Development Status and Outlook

6.1 Europe Breakthrough Therapy (BT) Designation Market Size (2013-2018)

6.2 Europe Breakthrough Therapy (BT) Designation Market Size and Market Share by Players (2013-2018)

6.3 Europe Breakthrough Therapy (BT) Designation Market Size by Application (2013-2018)

7 China Breakthrough Therapy (BT) Designation Development Status and Outlook

7.1 China Breakthrough Therapy (BT) Designation Market Size (2013-2018)

7.2 China Breakthrough Therapy (BT) Designation Market Size and Market Share by Players (2013-2018)

7.3 China Breakthrough Therapy (BT) Designation Market Size by Application (2013-2018)

8 Japan Breakthrough Therapy (BT) Designation Development Status and Outlook

8.1 Japan Breakthrough Therapy (BT) Designation Market Size (2013-2018)

8.2 Japan Breakthrough Therapy (BT) Designation Market Size and Market Share by Players (2013-2018)

8.3 Japan Breakthrough Therapy (BT) Designation Market Size by Application (2013-2018)

9 Southeast Asia Breakthrough Therapy (BT) Designation Development Status and Outlook

9.1 Southeast Asia Breakthrough Therapy (BT) Designation Market Size (2013-2018)

9.2 Southeast Asia Breakthrough Therapy (BT) Designation Market Size and Market Share by Players (2013-2018)

9.3 Southeast Asia Breakthrough Therapy (BT) Designation Market Size by Application (2013-2018)

10 India Breakthrough Therapy (BT) Designation Development Status and Outlook

10.1 India Breakthrough Therapy (BT) Designation Market Size (2013-2018)

10.2 India Breakthrough Therapy (BT) Designation Market Size and Market Share by Players (2013-2018)

10.3 India Breakthrough Therapy (BT) Designation Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)

11.1 Global Breakthrough Therapy (BT) Designation Market Size (Value) by Regions (2018-2025)

11.1.1 United States Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2018-2025)

11.1.2 Europe Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2018-2025)

11.1.3 China Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2018-2025)

11.1.4 Japan Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2018-2025)

11.1.5 Southeast Asia Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2018-2025)

11.1.6 India Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2018-2025)

11.2 Global Breakthrough Therapy (BT) Designation Market Size (Value) by Type (2018-2025)

11.3 Global Breakthrough Therapy (BT) Designation Market Size by Application (2018-2025)

12 Breakthrough Therapy (BT) Designation Market Dynamics

12.1 Breakthrough Therapy (BT) Designation Market Opportunities

12.2 Breakthrough Therapy (BT) Designation Challenge and Risk

12.2.1 Competition from Opponents

12.2.2 Downside Risks of Economy

12.3 Breakthrough Therapy (BT) Designation Market Constraints and Threat

12.3.1 Threat from Substitute

12.3.2 Government Policy

12.3.3 Technology Risks

12.4 Breakthrough Therapy (BT) Designation Market Driving Force

12.4.1 Growing Demand from Emerging Markets

12.4.2 Potential Application

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs Trend/Customer Preference

13.3 External Environmental Change

13.3.1 Economic Fluctuations

13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix

Methodology

Analyst Introduction

Data Source

Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
Choose License Type



Why Choose Us

  24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Email: sales@marketresearchplace.com

  Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

  Information security

Your personal and confidential information is safe and secure.